Home > > > > Report Detail

2022-2029 Global Biosimilar Monoclonal Antibodies Professional Market Research Report, Analysis from Perspective of Segmentation (Competitor Landscape, Type, Application, and Geography)

Publisher Name :
Date: 05-Apr-2022
No. of pages: 105

The Biosimilar Monoclonal Antibodies market has witnessed growth from USD XX million to USD XX million from 2017 to 2022. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2029.

The report focuses on the Biosimilar Monoclonal Antibodies market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides detailed cost analysis, supply chain.

Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Consumer behavior analysis and market dynamics (drivers, restraints, opportunities) provides crucial information for knowing the Biosimilar Monoclonal Antibodies market.

Key players in the global Biosimilar Monoclonal Antibodies market covered in Chapter 2 and Chapter 6:

Shanghai CP Guojian Pharmaceutical

Samsung

Dr Reddy's

Zydus

Amgen

Celltrion

Hospira

Sandoz

Boehringer Ingelheim

In Chapter 8 and Chapter 10.3, based on types, the Biosimilar Monoclonal Antibodies market from 2017 to 2029 is primarily split into:

Infliximab

Rituximab

Trastuzumab

Adalimumab

Other

In Chapter 9 and Chapter 10.4, based on applications, the Biosimilar Monoclonal Antibodies market from 2017 to 2029 covers:

Oncology

Autoimmune Disease

Other

Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2017 -2029) of the following regions:

United States

Europe (Germany, UK, France, Italy, Spain, Russia, Poland)

China

Japan

India

Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)

Latin America (Brazil, Mexico, Colombia)

Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)

Other Regions

Chapter 1 provides an overview of Biosimilar Monoclonal Antibodies market, containing global revenue and CAGR. The forecast and analysis of Biosimilar Monoclonal Antibodies market by type, application, and region are also presented in this chapter.

Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.

Chapter 3 introduces the industrial chain of Biosimilar Monoclonal Antibodies. Industrial chain analysis, raw material (suppliers, price, supply and demand, market concentration rate) and downstream buyers are analyzed in this chapter.

Chapter 4 concentrates on manufacturing analysis, including cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.

Chapter 5 provides clear insights into market dynamics, the influence of COVID-19 in Biosimilar Monoclonal Antibodies industry, consumer behavior analysis.

Chapter 6 provides a full-scale analysis of major players in Biosimilar Monoclonal Antibodies industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.

Chapter 7 pays attention to the sales, revenue, price and gross margin of Biosimilar Monoclonal Antibodies in markets of different regions. The analysis on sales, revenue, price and gross margin of the global market is covered in this part.

Chapter 8 gives a worldwide view of Biosimilar Monoclonal Antibodies market. It includes sales, revenue, price, market share and the growth rate by type.

Chapter 9 focuses on the application of Biosimilar Monoclonal Antibodies, by analyzing the consumption and its growth rate of each application.

Chapter 10 prospects the whole Biosimilar Monoclonal Antibodies market, including the global sales and revenue forecast, regional forecast. It also foresees the Biosimilar Monoclonal Antibodies market by type and application.

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2029

2022-2029 Global Biosimilar Monoclonal Antibodies Professional Market Research Report, Analysis from Perspective of Segmentation (Competitor Landscape, Type, Application, and Geography)

Table of Content

1 Biosimilar Monoclonal Antibodies Market Overview
1.1 Product Overview and Scope of Biosimilar Monoclonal Antibodies
1.2 Biosimilar Monoclonal Antibodies Segment by Type
1.2.1 Global Biosimilar Monoclonal Antibodies Sales and CAGR (%) Comparison by Type (2017-2029)
1.2.2 The Market Profile of Infliximab
1.2.3 The Market Profile of Rituximab
1.2.4 The Market Profile of Trastuzumab
1.2.5 The Market Profile of Adalimumab
1.2.6 The Market Profile of Other
1.3 Global Biosimilar Monoclonal Antibodies Segment by Application
1.3.1 Biosimilar Monoclonal Antibodies Consumption (Sales) Comparison by Application (2017-2029)
1.3.2 The Market Profile of Oncology
1.3.3 The Market Profile of Autoimmune Disease
1.3.4 The Market Profile of Other
1.4 Global Biosimilar Monoclonal Antibodies Market, Region Wise (2017-2022)
1.4.1 Global Biosimilar Monoclonal Antibodies Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2022)
1.4.2 United States Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.3 Europe Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.3.1 Germany Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.3.2 UK Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.3.3 France Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.3.4 Italy Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.3.5 Spain Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.3.6 Russia Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.3.7 Poland Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.4 China Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.5 Japan Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.6 India Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.7 Southeast Asia Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.7.1 Malaysia Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.7.2 Singapore Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.7.3 Philippines Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.7.4 Indonesia Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.7.5 Thailand Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.7.6 Vietnam Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.8 Latin America Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.8.1 Brazil Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.8.2 Mexico Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.8.3 Colombia Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.9 Middle East and Africa Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.9.1 Saudi Arabia Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.9.2 United Arab Emirates Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.9.3 Turkey Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.9.4 Egypt Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.9.5 South Africa Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.9.6 Nigeria Biosimilar Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.5 Global Market Size of Biosimilar Monoclonal Antibodies (2017-2029)
1.5.1 Global Biosimilar Monoclonal Antibodies Revenue Status and Outlook (2017-2029)
1.5.2 Global Biosimilar Monoclonal Antibodies Sales Status and Outlook (2017-2029)

2 Global Biosimilar Monoclonal Antibodies Market Landscape by Player
2.1 Global Biosimilar Monoclonal Antibodies Sales and Share by Player (2017-2022)
2.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Player (2017-2022)
2.3 Global Biosimilar Monoclonal Antibodies Average Price by Player (2017-2022)
2.4 Global Biosimilar Monoclonal Antibodies Gross Margin by Player (2017-2022)
2.5 Biosimilar Monoclonal Antibodies Manufacturing Base Distribution, Sales Area and Product Type by Player
2.6 Biosimilar Monoclonal Antibodies Market Competitive Situation and Trends
2.6.1 Biosimilar Monoclonal Antibodies Market Concentration Rate
2.6.2 Biosimilar Monoclonal Antibodies Market Share of Top 3 and Top 6 Players
2.6.3 Mergers & Acquisitions, Expansion

3 Biosimilar Monoclonal Antibodies Upstream and Downstream Analysis
3.1 Biosimilar Monoclonal Antibodies Industrial Chain Analysis
3.2 Key Raw Materials Suppliers and Price Analysis
3.3 Key Raw Materials Supply and Demand Analysis
3.4 Manufacturing Process Analysis
3.5 Market Concentration Rate of Raw Materials
3.6 Downstream Buyers
3.7 Value Chain Status Under COVID-18

4 Biosimilar Monoclonal Antibodies Manufacturing Cost Analysis
4.1 Manufacturing Cost Structure Analysis
4.2 Biosimilar Monoclonal Antibodies Key Raw Materials Cost Analysis
4.2.1 Key Raw Materials Introduction
4.2.2 Price Trend of Key Raw Materials
4.3 Labor Cost Analysis
4.3.1 Labor Cost of Biosimilar Monoclonal Antibodies Under COVID-19
4.4 Energy Costs Analysis
4.5 R&D Costs Analysis

5 Market Dynamics
5.1 Drivers
5.2 Restraints and Challenges
5.3 Opportunities
5.3.1 Advances in Innovation and Technology for Biosimilar Monoclonal Antibodies
5.3.2 Increased Demand in Emerging Markets
5.4 Biosimilar Monoclonal Antibodies Industry Development Trends under COVID-19 Outbreak
5.4.1 Global COVID-19 Status Overview
5.4.2 Influence of COVID-19 Outbreak on Biosimilar Monoclonal Antibodies Industry Development
5.5 Consumer Behavior Analysis

6 Players Profiles
6.1 Shanghai CP Guojian Pharmaceutical
6.1.1 Shanghai CP Guojian Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
6.1.2 Biosimilar Monoclonal Antibodies Product Profiles, Application and Specification
6.1.3 Shanghai CP Guojian Pharmaceutical Biosimilar Monoclonal Antibodies Market Performance (2017-2022)
6.1.4 Shanghai CP Guojian Pharmaceutical Business Overview
6.2 Samsung
6.2.1 Samsung Basic Information, Manufacturing Base, Sales Area and Competitors
6.2.2 Biosimilar Monoclonal Antibodies Product Profiles, Application and Specification
6.2.3 Samsung Biosimilar Monoclonal Antibodies Market Performance (2017-2022)
6.2.4 Samsung Business Overview
6.3 Dr Reddy's
6.3.1 Dr Reddy's Basic Information, Manufacturing Base, Sales Area and Competitors
6.3.2 Biosimilar Monoclonal Antibodies Product Profiles, Application and Specification
6.3.3 Dr Reddy's Biosimilar Monoclonal Antibodies Market Performance (2017-2022)
6.3.4 Dr Reddy's Business Overview
6.4 Zydus
6.4.1 Zydus Basic Information, Manufacturing Base, Sales Area and Competitors
6.4.2 Biosimilar Monoclonal Antibodies Product Profiles, Application and Specification
6.4.3 Zydus Biosimilar Monoclonal Antibodies Market Performance (2017-2022)
6.4.4 Zydus Business Overview
6.5 Amgen
6.5.1 Amgen Basic Information, Manufacturing Base, Sales Area and Competitors
6.5.2 Biosimilar Monoclonal Antibodies Product Profiles, Application and Specification
6.5.3 Amgen Biosimilar Monoclonal Antibodies Market Performance (2017-2022)
6.5.4 Amgen Business Overview
6.6 Celltrion
6.6.1 Celltrion Basic Information, Manufacturing Base, Sales Area and Competitors
6.6.2 Biosimilar Monoclonal Antibodies Product Profiles, Application and Specification
6.6.3 Celltrion Biosimilar Monoclonal Antibodies Market Performance (2017-2022)
6.6.4 Celltrion Business Overview
6.7 Hospira
6.7.1 Hospira Basic Information, Manufacturing Base, Sales Area and Competitors
6.7.2 Biosimilar Monoclonal Antibodies Product Profiles, Application and Specification
6.7.3 Hospira Biosimilar Monoclonal Antibodies Market Performance (2017-2022)
6.7.4 Hospira Business Overview
6.8 Sandoz
6.8.1 Sandoz Basic Information, Manufacturing Base, Sales Area and Competitors
6.8.2 Biosimilar Monoclonal Antibodies Product Profiles, Application and Specification
6.8.3 Sandoz Biosimilar Monoclonal Antibodies Market Performance (2017-2022)
6.8.4 Sandoz Business Overview
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Competitors
6.9.2 Biosimilar Monoclonal Antibodies Product Profiles, Application and Specification
6.9.3 Boehringer Ingelheim Biosimilar Monoclonal Antibodies Market Performance (2017-2022)
6.9.4 Boehringer Ingelheim Business Overview

7 Global Biosimilar Monoclonal Antibodies Sales and Revenue Region Wise (2017-2022)
7.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share, Region Wise (2017-2022)
7.2 Global Biosimilar Monoclonal Antibodies Revenue (Revenue) and Market Share, Region Wise (2017-2022)
7.3 Global Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2022)
7.4.1 United States Biosimilar Monoclonal Antibodies Market Under COVID-19
7.5 Europe Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2022)
7.5.1 Europe Biosimilar Monoclonal Antibodies Market Under COVID-19
7.6 China Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2022)
7.6.1 China Biosimilar Monoclonal Antibodies Market Under COVID-19
7.7 Japan Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2022)
7.7.1 Japan Biosimilar Monoclonal Antibodies Market Under COVID-19
7.8 India Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2022)
7.8.1 India Biosimilar Monoclonal Antibodies Market Under COVID-19
7.9 Southeast Asia Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2022)
7.9.1 Southeast Asia Biosimilar Monoclonal Antibodies Market Under COVID-19
7.10 Latin America Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2022)
7.10.1 Latin America Biosimilar Monoclonal Antibodies Market Under COVID-19
7.11 Middle East and Africa Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2022)
7.11.1 Middle East and Africa Biosimilar Monoclonal Antibodies Market Under COVID-19

8 Global Biosimilar Monoclonal Antibodies Sales, Revenue (Revenue), Price Trend by Type
8.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Type (2017-2022)
8.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2017-2022)
8.3 Global Biosimilar Monoclonal Antibodies Price by Type (2017-2022)
8.4 Global Biosimilar Monoclonal Antibodies Sales Growth Rate by Type (2017-2022)
8.4.1 Global Biosimilar Monoclonal Antibodies Sales Growth Rate of Infliximab (2017-2022)
8.4.2 Global Biosimilar Monoclonal Antibodies Sales Growth Rate of Rituximab (2017-2022)
8.4.3 Global Biosimilar Monoclonal Antibodies Sales Growth Rate of Trastuzumab (2017-2022)
8.4.4 Global Biosimilar Monoclonal Antibodies Sales Growth Rate of Adalimumab (2017-2022)
8.4.5 Global Biosimilar Monoclonal Antibodies Sales Growth Rate of Other (2017-2022)

9 Global Biosimilar Monoclonal Antibodies Market Analysis by Application
9.1 Global Biosimilar Monoclonal Antibodies Consumption and Market Share by Application (2017-2022)
9.2 Global Biosimilar Monoclonal Antibodies Consumption Growth Rate by Application (2017-2022)
9.2.1 Global Biosimilar Monoclonal Antibodies Consumption Growth Rate of Oncology (2017-2022)
9.2.2 Global Biosimilar Monoclonal Antibodies Consumption Growth Rate of Autoimmune Disease (2017-2022)
9.2.3 Global Biosimilar Monoclonal Antibodies Consumption Growth Rate of Other (2017-2022)

10 Global Biosimilar Monoclonal Antibodies Market Forecast (2022-2029)
10.1 Global Biosimilar Monoclonal Antibodies Sales, Revenue Forecast (2022-2029)
10.1.1 Global Biosimilar Monoclonal Antibodies Sales and Growth Rate Forecast (2022-2029)
10.1.2 Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast (2022-2029)
10.1.3 Global Biosimilar Monoclonal Antibodies Price and Trend Forecast (2022-2029)
10.2 Global Biosimilar Monoclonal Antibodies Sales and Revenue Forecast, Region Wise (2022-2029)
10.2.1 United States Biosimilar Monoclonal Antibodies Sales and Revenue Forecast (2022-2029)
10.2.2 Europe Biosimilar Monoclonal Antibodies Sales and Revenue Forecast (2022-2029)
10.2.3 China Biosimilar Monoclonal Antibodies Sales and Revenue Forecast (2022-2029)
10.2.4 Japan Biosimilar Monoclonal Antibodies Sales and Revenue Forecast (2022-2029)
10.2.5 India Biosimilar Monoclonal Antibodies Sales and Revenue Forecast (2022-2029)
10.2.6 Southeast Asia Biosimilar Monoclonal Antibodies Sales and Revenue Forecast (2022-2029)
10.2.7 Latin America Biosimilar Monoclonal Antibodies Sales and Revenue Forecast (2022-2029)
10.2.8 Middle East and Africa Biosimilar Monoclonal Antibodies Sales and Revenue Forecast (2022-2029)
10.3 Global Biosimilar Monoclonal Antibodies Sales, Revenue and Price Forecast by Type (2022-2029)
10.4 Global Biosimilar Monoclonal Antibodies Consumption Forecast by Application (2022-2029)
10.5 Biosimilar Monoclonal Antibodies Market Forecast Under COVID-19

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Data Source

List of Tables and Figures

Figure Biosimilar Monoclonal Antibodies Product Picture
Table Global Biosimilar Monoclonal Antibodies Sales and CAGR (%) Comparison by Type
Table Profile of Infliximab
Table Profile of Rituximab
Table Profile of Trastuzumab
Table Profile of Adalimumab
Table Profile of Other
Table Biosimilar Monoclonal Antibodies Consumption (Sales) Comparison by Application (2017-2029)
Table Profile of Oncology
Table Profile of Autoimmune Disease
Table Profile of Other
Figure Global Biosimilar Monoclonal Antibodies Market Size (Revenue) and CAGR (%) (2017-2022)
Figure United States Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure Europe Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure Germany Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure UK Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure France Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure Italy Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure Spain Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure Russia Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure Poland Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure China Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure Japan Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure India Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure Malaysia Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure Singapore Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure Philippines Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure Indonesia Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure Thailand Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure Vietnam Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure Latin America Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure Brazil Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure Mexico Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure Colombia Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure Middle East and Africa Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure Saudi Arabia Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure United Arab Emirates Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure Turkey Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure Egypt Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure South Africa Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure Nigeria Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Sales Status and Outlook (2017-2029)
Table Global Biosimilar Monoclonal Antibodies Sales by Player (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Sales Share by Player (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Sales Share by Player in 2021
Table Biosimilar Monoclonal Antibodies Revenue by Player (2017-2022)
Table Biosimilar Monoclonal Antibodies Revenue Market Share by Player (2017-2022)
Table Biosimilar Monoclonal Antibodies Price by Player (2017-2022)
Table Biosimilar Monoclonal Antibodies Gross Margin by Player (2017-2022)
Table Biosimilar Monoclonal Antibodies Manufacturing Base Distribution and Sales Area by Player
Table Biosimilar Monoclonal Antibodies Product Type by Player
Table Mergers & Acquisitions, Expansion Plans
Figure Biosimilar Monoclonal Antibodies Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Market Concentration Rate of Raw Materials
Table Downstream Buyers
Figure Manufacturing Cost Structure Analysis
Table Key Raw Materials Introduction of Biosimilar Monoclonal Antibodies
Figure Price Trend of Key Raw Materials
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Biosimilar Monoclonal Antibodies Industry Development
Table Shanghai CP Guojian Pharmaceutical Profile
Table Biosimilar Monoclonal Antibodies Product Profiles, Application and Specification
Table Shanghai CP Guojian Pharmaceutical Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Shanghai CP Guojian Pharmaceutical Revenue and Growth Rate
Figure Shanghai CP Guojian Pharmaceutical Revenue Market Share 2017-2022
Table Samsung Profile
Table Biosimilar Monoclonal Antibodies Product Profiles, Application and Specification
Table Samsung Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Samsung Revenue and Growth Rate
Figure Samsung Revenue Market Share 2017-2022
Table Dr Reddy's Profile
Table Biosimilar Monoclonal Antibodies Product Profiles, Application and Specification
Table Dr Reddy's Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Dr Reddy's Revenue and Growth Rate
Figure Dr Reddy's Revenue Market Share 2017-2022
Table Zydus Profile
Table Biosimilar Monoclonal Antibodies Product Profiles, Application and Specification
Table Zydus Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Zydus Revenue and Growth Rate
Figure Zydus Revenue Market Share 2017-2022
Table Amgen Profile
Table Biosimilar Monoclonal Antibodies Product Profiles, Application and Specification
Table Amgen Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Amgen Revenue and Growth Rate
Figure Amgen Revenue Market Share 2017-2022
Table Celltrion Profile
Table Biosimilar Monoclonal Antibodies Product Profiles, Application and Specification
Table Celltrion Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Celltrion Revenue and Growth Rate
Figure Celltrion Revenue Market Share 2017-2022
Table Hospira Profile
Table Biosimilar Monoclonal Antibodies Product Profiles, Application and Specification
Table Hospira Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Hospira Revenue and Growth Rate
Figure Hospira Revenue Market Share 2017-2022
Table Sandoz Profile
Table Biosimilar Monoclonal Antibodies Product Profiles, Application and Specification
Table Sandoz Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Sandoz Revenue and Growth Rate
Figure Sandoz Revenue Market Share 2017-2022
Table Boehringer Ingelheim Profile
Table Biosimilar Monoclonal Antibodies Product Profiles, Application and Specification
Table Boehringer Ingelheim Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Boehringer Ingelheim Revenue and Growth Rate
Figure Boehringer Ingelheim Revenue Market Share 2017-2022
Table Global Biosimilar Monoclonal Antibodies Sales, Region Wise (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Sales Market Share, Region Wise (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share, Region Wise (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share, Region Wise in 2021
Table Global Biosimilar Monoclonal Antibodies Revenue, Region Wise (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Revenue Market Share, Region Wise (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share, Region Wise (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share, Region Wise in 2021
Table Global Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2022)
Table United States Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2022)
Table Europe Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2022)
Table China Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2022)
Table Japan Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2022)
Table India Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2022)
Table Southeast Asia Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2022)
Table Latin America Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2022)
Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Sales by Type (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Type (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2022
Table Global Biosimilar Monoclonal Antibodies Revenue by Type (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type in 2022
Table Biosimilar Monoclonal Antibodies Price by Type (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Sales Growth Rate of Infliximab (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Sales Growth Rate of Rituximab (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Sales Growth Rate of Trastuzumab (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Sales Growth Rate of Adalimumab (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Sales Growth Rate of Other (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Consumption by Application (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Consumption of Oncology (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Consumption of Autoimmune Disease (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Consumption of Other (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Sales and Growth Rate Forecast (2022-2029)
Figure Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast (2022-2029)
Figure Global Biosimilar Monoclonal Antibodies Price and Trend Forecast (2022-2029)
Figure USA Biosimilar Monoclonal Antibodies Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure USA Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure Europe Biosimilar Monoclonal Antibodies Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Europe Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure China Biosimilar Monoclonal Antibodies Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure China Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure Japan Biosimilar Monoclonal Antibodies Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Japan Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure India Biosimilar Monoclonal Antibodies Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure India Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure Latin America Biosimilar Monoclonal Antibodies Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Latin America Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure Middle East and Africa Biosimilar Monoclonal Antibodies Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Middle East and Africa Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Table Global Biosimilar Monoclonal Antibodies Market Sales Forecast, by Type
Table Global Biosimilar Monoclonal Antibodies Sales Volume Market Share Forecast, by Type
Table Global Biosimilar Monoclonal Antibodies Market Revenue Forecast, by Type
Table Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast, by Type
Table Global Biosimilar Monoclonal Antibodies Price Forecast, by Type
Table Global Biosimilar Monoclonal Antibodies Market Consumption Forecast, by Application
Table Global Biosimilar Monoclonal Antibodies Consumption Volume Market Share Forecast, by Application
Table Global Biosimilar Monoclonal Antibodies Market Revenue Forecast, by Application
Table Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast, by Application
Table Global Biosimilar Monoclonal Antibodies Price Forecast, by Application
  • Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147
    According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......
  • Global Biosimilar Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......
  • Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147
    According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......
  • Global Biosimilars Market Research Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167
    A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
  • Global Biosimilars Professional Survey Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133
    A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
  • Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......
  • Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134
    Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
  • Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160
    Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
  • Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs